abnova.com · 497
Abnova is the world's largest antibody and recombinant protein manufacturer, offering over 45,000 antibodies/antigens, 19,000 recombinant proteins, 3,000 antibody pairs/kits, and more. Their wide range of products and services cater to researchers and scientists in the fields of molecular biology, biochemistry, and cell biology. Abnova's commitment to innovation and quality has established them as a leading supplier in the life sciences industry. With a focus on customer satisfaction and product excellence, Abnova continues to expand its product offerings and services to meet the evolving needs of the scientific community.
abnova.com · years statistic
2002
| 1 | 0 |
| 2 | 0 |
| 3 | 0 |
| 4 | 0 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 2 |
| 10 | 0 |
| 11 | 1 |
| 12 | 1 |
2003
| 1 | 0 |
| 2 | 0 |
| 3 | 1 |
| 4 | 1 |
| 5 | 0 |
| 6 | 0 |
| 7 | 1 |
| 8 | 0 |
| 9 | 0 |
| 10 | 2 |
| 11 | 0 |
| 12 | 2 |
2004
| 1 | 1 |
| 2 | 0 |
| 3 | 2 |
| 4 | 0 |
| 5 | 0 |
| 6 | 2 |
| 7 | 0 |
| 8 | 1 |
| 9 | 1 |
| 10 | 0 |
| 11 | 0 |
| 12 | 1 |
2005
| 1 | 0 |
| 2 | 1 |
| 3 | 0 |
| 4 | 0 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 0 |
| 11 | 1 |
| 12 | 0 |
2006
| 1 | 0 |
| 2 | 0 |
| 3 | 0 |
| 4 | 0 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 1 |
| 9 | 0 |
| 10 | 0 |
| 11 | 2 |
| 12 | 1 |
2007
| 1 | 0 |
| 2 | 0 |
| 3 | 1 |
| 4 | 0 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
2008
| 1 | 0 |
| 2 | 0 |
| 3 | 0 |
| 4 | 0 |
| 5 | 0 |
| 6 | 0 |
| 7 | 5 |
| 8 | 2 |
| 9 | 2 |
| 10 | 3 |
| 11 | 1 |
| 12 | 2 |
2009
| 1 | 1 |
| 2 | 6 |
| 3 | 2 |
| 4 | 0 |
| 5 | 1 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
2010
| 1 | 1 |
| 2 | 1 |
| 3 | 0 |
| 4 | 0 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 0 |
| 11 | 2 |
| 12 | 2 |
2011
| 1 | 1 |
| 2 | 2 |
| 3 | 0 |
| 4 | 1 |
| 5 | 1 |
| 6 | 0 |
| 7 | 1 |
| 8 | 4 |
| 9 | 5 |
| 10 | 14 |
| 11 | 10 |
| 12 | 10 |
2012
| 1 | 1 |
| 2 | 2 |
| 3 | 3 |
| 4 | 4 |
| 5 | 5 |
| 6 | 5 |
| 7 | 3 |
| 8 | 2 |
| 9 | 1 |
| 10 | 4 |
| 11 | 5 |
| 12 | 6 |
2013
| 1 | 2 |
| 2 | 3 |
| 3 | 3 |
| 4 | 10 |
| 5 | 12 |
| 6 | 0 |
| 7 | 3 |
| 8 | 7 |
| 9 | 0 |
| 10 | 1 |
| 11 | 0 |
| 12 | 1 |
2014
| 1 | 0 |
| 2 | 1 |
| 3 | 0 |
| 4 | 0 |
| 5 | 2 |
| 6 | 0 |
| 7 | 2 |
| 8 | 1 |
| 9 | 0 |
| 10 | 1 |
| 11 | 0 |
| 12 | 3 |
2015
| 1 | 0 |
| 2 | 8 |
| 3 | 5 |
| 4 | 3 |
| 5 | 2 |
| 6 | 0 |
| 7 | 1 |
| 8 | 5 |
| 9 | 6 |
| 10 | 6 |
| 11 | 4 |
| 12 | 4 |
2016
| 1 | 6 |
| 2 | 0 |
| 3 | 5 |
| 4 | 3 |
| 5 | 2 |
| 6 | 3 |
| 7 | 3 |
| 8 | 2 |
| 9 | 3 |
| 10 | 3 |
| 11 | 2 |
| 12 | 1 |
2017
| 1 | 0 |
| 2 | 0 |
| 3 | 0 |
| 4 | 3 |
| 5 | 1 |
| 6 | 6 |
| 7 | 2 |
| 8 | 5 |
| 9 | 2 |
| 10 | 1 |
| 11 | 2 |
| 12 | 2 |
2018
| 1 | 1 |
| 2 | 1 |
| 3 | 5 |
| 4 | 4 |
| 5 | 5 |
| 6 | 3 |
| 7 | 5 |
| 8 | 6 |
| 9 | 4 |
| 10 | 5 |
| 11 | 5 |
| 12 | 7 |
2019
| 1 | 6 |
| 2 | 5 |
| 3 | 3 |
| 4 | 3 |
| 5 | 0 |
| 6 | 0 |
| 7 | 1 |
| 8 | 0 |
| 9 | 2 |
| 10 | 0 |
| 11 | 0 |
| 12 | 1 |
2020
| 1 | 0 |
| 2 | 1 |
| 3 | 1 |
| 4 | 1 |
| 5 | 5 |
| 6 | 4 |
| 7 | 2 |
| 8 | 2 |
| 9 | 4 |
| 10 | 3 |
| 11 | 3 |
| 12 | 1 |
2021
| 1 | 1 |
| 2 | 0 |
| 3 | 2 |
| 4 | 1 |
| 5 | 2 |
| 6 | 7 |
| 7 | 1 |
| 8 | 1 |
| 9 | 3 |
| 10 | 3 |
| 11 | 1 |
| 12 | 3 |
2022
| 1 | 2 |
| 2 | 6 |
| 3 | 6 |
| 4 | 1 |
| 5 | 3 |
| 6 | 1 |
| 7 | 11 |
| 8 | 3 |
| 9 | 2 |
| 10 | 3 |
| 11 | 1 |
| 12 | 5 |
2023
| 1 | 2 |
| 2 | 1 |
| 3 | 7 |
| 4 | 1 |
| 5 | 2 |
| 6 | 4 |
| 7 | 1 |
| 8 | 4 |
| 9 | 0 |
| 10 | 1 |
| 11 | 1 |
| 12 | 1 |
2024
| 1 | 0 |
| 2 | 1 |
| 3 | 2 |
| 4 | 1 |
| 5 | 0 |
| 6 | 0 |
| 7 | 0 |
| 8 | 0 |
| 9 | 0 |
| 10 | 0 |
| 11 | 0 |
| 12 | 0 |
